Polaris AI Pharma Corp.
A global supplier of generic APIs using AI to accelerate drug development.
041910 | KO
Overview
Corporate Details
- ISIN(s):
- KR7041910001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 발안공단로 25, 화성시
- Website:
- https://polarisaipharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Polaris AI Pharma Corp., formerly Estechpharma, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs). The company specializes in the production of generic APIs, with a portfolio of approximately 40 products for various therapeutic areas, including anti-thrombotic, anti-inflammatory, and treatments for gastric ulcers and asthma. A key strategic focus is the integration of artificial intelligence into its research and development pipeline to predict the success of drug candidates and optimize clinical trial designs, thereby accelerating the development process. Polaris AI Pharma serves both domestic and international pharmaceutical markets and engages in joint research for innovative drug delivery systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 884.1 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-08-12 00:00 |
M&A Activity
[기재정정]주요사항보고서(유형자산양수결정)
|
Korean | 19.8 KB | ||
| 2025-08-12 00:00 |
M&A Activity
합병등종료보고서(자산양수도)
|
Korean | 15.7 KB | ||
| 2025-08-07 00:00 |
M&A Activity
[기재정정]주요사항보고서(유형자산양수결정)
|
Korean | 20.0 KB | ||
| 2025-08-01 00:00 |
Capital/Financing Update
단기차입금증가결정
|
Korean | 9.5 KB | ||
| 2025-07-07 00:00 |
M&A Activity
주요사항보고서(유형자산양수결정)
|
Korean | 15.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 907.9 KB | ||
| 2025-03-20 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 18.5 KB | ||
| 2025-03-12 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 540.9 KB | ||
| 2025-03-12 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 19.4 KB | ||
| 2025-03-05 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.4 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 7.9 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 118.6 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.5 KB |
Automate Your Workflow. Get a real-time feed of all Polaris AI Pharma Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Polaris AI Pharma Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Polaris AI Pharma Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
